Alemtuzumab induction in renal transplantation. - Wikidata - wikimedia - TriplyDB

Alemtuzumab induction in renal transplantation.

Alemtuzumab induction in renal transplantation.

http://www.wikidata.org/entity/Q34660489

about

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity Monoclonal antibody therapy and renal transplantation: focus on adverse effects Patient involvement in selection of immunosuppressive regimen following transplantation Biologics in organ transplantation Current state of renal transplant immunosuppression: Present and future Selection of induction therapy in kidney transplantation Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study.Is it safe to withdraw steroids within seven days of renal transplantation?Immunosuppressive Medications.A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.Diagnosis and management of antibody-mediated rejection: current status and novel approaches.Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.Association of antibody induction immunosuppression with cancer after kidney transplantation.Novel and emerging targeted-based cancer therapy agents and methods.Poor outcomes in elderly kidney transplant recipients receiving alemtuzumab induction.Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance Tolerogenic therapies in transplantation.Outcomes Associated with Steroid Avoidance and Alemtuzumab among Kidney Transplant Recipients Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.Alemtuzumab induction in pediatric kidney transplantation.HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles.Alemtuzumab as compared to alternative contemporary induction regimens.Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab.Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study.Acute transplant glomerulopathy with monocyte rich infiltrate.Corticosteroid minimization in renal transplantation: Careful patient selection enables feasibility.Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol.Emerging drugs for the treatment of transplant rejection.Induction therapy in renal transplant recipients: how convincing is the current evidence?Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.Effects of immunoglobulin to prevent coronary allograft vasculopathy in heart transplantation.The role of Thymoglobulin induction in kidney transplantation: an update.Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinician.Induction immunosuppression in liver transplantation: a review.

P2860

Q26774993-A2A9BB19-857B-4FC2-9B0A-C9B25849A673 Q26823090-1665EDCD-4409-48DA-8281-A79425788127 Q26826880-903155A6-6091-45EC-964D-5FB335CD2DA6 Q26829069-C89E8B3C-BC05-4403-BF0D-35C01AA14C4D Q26829578-BA3B0A35-6E9D-4022-861B-58B36D3255C9 Q26829789-AE5F9C4B-A612-45A0-B8E0-1560E7F59E65 Q26864234-64741640-67A3-4418-981B-12FB9BA4DA30 Q30239091-73CE1268-8A2A-44D8-8E06-3710FA08A983 Q30389408-F1A97560-FA0B-4876-820C-FC0E8B0246AD Q34027642-5D297D12-E782-4D48-8BB8-548314D23970 Q34448543-7B775AAA-B142-4DDE-BFDE-8CDB1D04E920 Q34484801-08A1DA74-F96D-4439-BC01-EBF7D591DE4F Q34796915-9EDA9ED7-CAD0-4244-B2D3-66399A9D0A0A Q34841849-319C24A5-C3B0-4CEF-8907-C4075C33FA6C Q35344810-6BC3E9AF-E90A-4FEA-A71D-012AF870022A Q35513074-04C85D4D-F6A2-4864-AFEA-E1479B638E75 Q35558057-2B29F3E5-9B7B-4B9E-AEA0-CB2C62E1F83B Q35611179-DD2C2770-FEF8-4C74-A4C5-04DD7A633B3F Q35682221-F50B773A-9B40-4EE9-8D0D-F13FFC6736F8 Q36102133-7E89EB10-E769-4D87-B7BF-488C7EECBA90 Q36250338-6EECF8D8-D3E9-42FA-827A-63BE4CCA48B7 Q36368036-D5D13DEB-53BB-494C-A5ED-236CA2770B3A Q36575860-1A8C015D-7AD7-4E7C-A781-08449F442D72 Q36818003-B4779EC5-7572-41F4-8E23-6E7845BBF296 Q36818017-67A6887B-1189-47BE-9654-36FF73D03D77 Q36880514-C2612F3C-DC97-434B-9CE8-6ADF692527B5 Q36908763-CCE95D95-077E-4FA2-909A-ED181FE153C2 Q37282011-61F35624-F3B6-468D-B3C6-57332692330B Q37346593-7FFBEC85-3029-4ED5-B99C-BAD688EDC7C5 Q37387510-C4AEC669-68E8-4B9D-B159-6219BA94509A Q37522631-5B86099A-5286-4B4F-AC73-911E4BF523AB Q37652611-531CDBBC-B5C9-4C9B-909F-9AA1F7618AB3 Q37662995-F0B17CA6-0414-48C0-89E8-45C923BCB40D Q37960177-D25832C2-FB62-4392-8331-1A1DA6225F18 Q37996078-7775A9EE-5969-4847-BCDE-75C8B7813505 Q38009874-046E765F-6C57-4F0D-9468-48112119F099 Q38023873-1B03E7F3-288E-4B1C-8868-3ED0512CCF7D Q38051718-FCD1B508-5D40-4C3F-B174-FAA9DB908704 Q38057787-C1F2186A-7B3A-4D70-AF2F-FECF06DCF9C5 Q38104751-2C3285F2-5332-4221-BF40-4EB2B14C92D7

P2860

Alemtuzumab induction in renal transplantation.

http://www.wikidata.org/entity/Q34660489

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Alemtuzumab induction in renal transplantation.

@ast

Alemtuzumab induction in renal transplantation.

@en

Alemtuzumab induction in renal transplantation.

@nl

type

label

Alemtuzumab induction in renal transplantation.

@ast

Alemtuzumab induction in renal transplantation.

@en

Alemtuzumab induction in renal transplantation.

@nl

prefLabel

Alemtuzumab induction in renal transplantation.

@ast

Alemtuzumab induction in renal transplantation.

@en

Alemtuzumab induction in renal transplantation.

@nl

P1433

Q34660489-3E8C8145-621F-4B39-B96D-24543008E4E7

P1476

Q34660489-2D20F93C-F4FA-46A9-8DF1-0D905D564820

P2093

Q34660489-07B5EDCB-C55D-48E5-9F71-D1B549348706

Q34660489-16BCCFE7-BEF5-453B-A177-461C7DE86CFD

Q34660489-315B4A43-CB0D-4F2B-9BEE-509E7D4A92FE

Q34660489-38D3C00C-0367-41E0-BD7F-C5A465E29976

Q34660489-477E7EAA-D3FE-4434-A8D2-8681F88C1E5D

Q34660489-4B0A19B2-8FEE-4A2D-8B39-3C384CC84C22

Q34660489-5069D392-D929-454D-9A87-18BA121CCB27

Q34660489-7B6D6CBE-17B1-4199-8C5C-FA5C9656A8C2

Q34660489-97F3FDE0-146C-4252-AB2A-9AD6D76B337E

P304

Q34660489-81E4D625-1AD1-419A-A202-706A3DB0E7C8

P31

Q34660489-F39625B4-2F8F-4568-9CCB-04D2519237A0

P356

Q34660489-76926EC4-5878-4F84-AF93-F2456680457F

P407

Q34660489-9977454A-B019-4F37-90BE-785CD205B0D4

P433

Q34660489-A0AE6493-6616-4177-9A57-90C07381317A

P478

Q34660489-D61B2DE6-2CCF-4F69-BFF4-043B01073DC2

P577

Q34660489-5477A650-A09B-42E1-9537-497D4BC94B0C

P698

Q34660489-A47804B3-B92C-4A02-AE3A-3D590653D96E

P356

P1433

The New England Journal of Medicine

P1476

Alemtuzumab induction in renal transplantation.

@en

P2093

Dixon B Kaufman

http://www.w3.org/2001/XMLSchema#string

E Steve Woodle

http://www.w3.org/2001/XMLSchema#string

INTAC Study Group

http://www.w3.org/2001/XMLSchema#string

John Holman

http://www.w3.org/2001/XMLSchema#string

M Roy First

http://www.w3.org/2001/XMLSchema#string

Michael J Hanaway

http://www.w3.org/2001/XMLSchema#string

Richard Croy

http://www.w3.org/2001/XMLSchema#string

Shamkant Mulgaonkar

http://www.w3.org/2001/XMLSchema#string

V Ram Peddi

http://www.w3.org/2001/XMLSchema#string

P304

1909-1919

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1009546

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

364

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21591943

http://www.w3.org/2001/XMLSchema#string